{
  "trial_id": "NCT01907334",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "parent/legal guardian and subject must be able to speak and understand English",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "patient must be willing and able to give assent to take part in the study",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "diagnosed with asthma for at least 6 months",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "able to demonstrate inhalation technique with study device",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "if taking inhaled corticosteroids, dose must be stable for 2 weeks",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "no significant concomitant medical conditions or abnormal physical findings on screening except for those consistent with asthma and allergic rhinitis",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "airway responsiveness to methacholine with a baseline provocational dose causing an increase of at least 40% in R5 (PC40R5) at no more than 8 mg/mL",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "female who has started menstruating",
      "label": "not_met",
      "evidence": "patient text"
    },
    {
      "criterion": "past or present history of any allergic reaction to any of the medications or formulations administered in this study",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "prior treatment with systemic corticosteroids in last 30 days or more than 4 courses in previous 12 months",
      "label": "not_met",
      "evidence": "patient text"
    },
    {
      "criterion": "use of short-acting beta-agonist more than two times per week in the previous month",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "use of long-acting beta-agonist in the 3 weeks before the first methacholine challenge or during the study",
      "label": "not_met",
      "evidence": "patient text"
    },
    {
      "criterion": "change in dosage of inhaled corticosteroids in previous 30 days, nasal steroids in previous 15 days and montelukast in last 7 days",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has myasthenia gravis, class IIa. She complains of diplopia and fatigue and weakness that affects mainly her upper limbs.",
  "_meta": {
    "topic_id": "38",
    "trial_id": "NCT01907334",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}